Medical devices provider, Teleflex (NYSE:TFX) said on Thursday that it will acquire all of the vascular intervention business ...

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also ...

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

Biotronik today announced a strategic shift that includes the divestiture of its Vascular Intervention (VI) business to ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...

Teleflex to separate into two companies by mid-2026 and acquire Biotronik's Vascular Intervention unit for €760 million. CFO ...

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Teleflex to create a new, independent publicly traded company consisting of its Urology, Acute Care, and OEM businesses.

Teleflex (NYSE: TFX) announced today that it plans to separate its Urology, Acute Care and OEM businesses into a new publicly ...

Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...

Teleflex (TFX) announced it has entered into a definitive agreement to acquire substantially all of the Vascular Intervention business of ...